Dr. Anna C. Eichhorn was born in 1972 in Frankfurt am Main. After completing a foundation course in chemistry and biology, she received a degree in biochemistry from the Johann Wolfgang Goethe University in Frankfurt am Main in 1998. Followed by the academic degree of Disputation in 2003. In 2001 Dr. Eichhorn founded the company Humatrix AG in Frankfurt am Main together with partners, assuming the Chief Technology Officer (CTO) role. She has been Chief Executive Officer (CEO) of Humatrix AG since 2012.
In a scientific environment, Dr Eichhorn acts as a Management Board member of the House of Pharma & Healthcare Association and as Deputy CEO of the Rhine-Main Healthcare Sector Initiative Association – both based in Frankfurt am Main. She is also a scientific consultant to the European Journal of Clinical Pharmacology (EJCP).
Dr. Eichhorn has been a member of the BRAIN Biotech AG Supervisory Board since March 9, 2017 and she is also Vice Chairwoman since March 5, 2020. She is elected until the end of the AGM in FY 2024/25.
Further memberships of statutory Supervisory Boards in Germany:
Further memberships in comparable German and foreign Supervisory Boards:
- Member of the Supervisory Board of the Frankfurter Innovationszentrum Biotechnologie GmbH (FiZ), Frankfurt am Main
Independent within the meaning of Section C.6, C.7 and C.9 of the German Corporate Governance Code:
Last update: November 2021